Wall Street Hot Runners: Molycorp Inc (NYSE:MCP), NQ Mobile (NYSE:NQ), IAMGOLD (NYSE:IAG), Magnum Hunter Resources (NYSE:MHR), Chelsea Therapeutics (NASDAQ:CHTP)

Molycorp Inc (NYSE:MCP) is said to have been downgraded to Underweight from Neutral by JPMorgan financial analysts. The JPMorgan bank downgraded Molycorp Inc (NYSE:MCP) to Underweight as soon as the company reported its Q1 results, stating that Molycorp will look for another capital raise likely this year. Molycorp Inc (NYSE:MCP) stock performance was 1.45% in last session and finished the day at $2.80. Traded volume was 7.37million shares in the last session and the average volume of the stock remained 4.75million shares. The beta of the stock remained 3.18. Molycorp Inc (NYSE:MCP) insider ownership is 19.60%.

NQ Mobile Inc (ADR) (NYSE:NQ) revealed last week that the independent investigation of its accounting practices found no evidence of fraud. However, it doesn’t look like the debate about the Chinese company’s accounting practices will be ending soon. NQ Mobile Inc (ADR) (NYSE:NQ) dropped -3.75 percent to $9.23 Tuesday on volume of 5.67million shares. The intra-day range of the stock was $9.16 to $9.99. NQ Mobile Inc (ADR) (NYSE:NQ) has a market capitalization of $445.39million.

IAMGOLD Corp (USA) (NYSE:IAG) on May 27 provided an update from ongoing exploration activities at its newly optioned Monster Lake project located 50 kilometres southwest of Chibougamau, Quebec, Canada. IAMGOLD Corp (USA) (NYSE:IAG)’s stock on June 10, 2014 reported a increase of 3.01% to the closing price of $3.77. Its fifty two weeks range is $3.00 -$7.08. The total market capitalization recorded $1.42billion. The overall volume in the last trading session was 5.88million shares. In its share capital, IAG has 375.79million outstanding shares.

Magnum Hunter Resources Corp (NYSE:MHR) SVP Donald L. Kirkendall sold 100,000 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $8.34, for a total transaction of $834,000.00. Following the transaction, the senior vice president now directly owns 100,000 shares in the company, valued at approximately $834,000. On Tuesday, shares of Magnum Hunter Resources Corp (NYSE:MHR) dropped -5.54% to close the day at $8.35. Company return on investment (ROI) is -11.40% and its monthly performance is recorded as 12.99%. Magnum Hunter Resources Corp (NYSE:MHR) quarterly revenue growth is 9.15%.

In January 2014, FDA’s Cardiovascular and Renal Drugs Advisory Committee voted 16 to 1 in favor of approval for Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)’s pipeline drug Northera (droxidopa), designed to prevent dizziness and fainting among patients with neurodegenerative diseases. Chelsea’s share price immediately soared 150%.Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock performance was -0.46% in last session and finished the day at $6.54. Traded volume was 6.28million shares in the last session and the average volume of the stock remained 4.04million shares. The beta of the stock remained 1.36. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) insider ownership is 1.00%.

[grabpress_video guid=”c77f01d905de7f7cf542ffdac687c74ebcb5b2cb”]